FDA has delineated the scope of its regulatory authority over cosmetics and suggested the need for reform measures in communications to stakeholders, but rarely so directly as in a recent letter to Sen. Dianne Feinstein, D-Calif., sponsor of the proposed Personal Care Products Safety Act.
According to Feinstein and co-sponsor Sen. Susan Collins, R-Maine, FDA was consulted extensively as the PCPSA, S. 1014, was being developed. However, the agency has been quiet on the bill...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?